Hebei Lansheng Biotech Co., Ltd.
ShangHai Yuelian Biotech Co., Ltd.

Isagro sales down 8% in Q1 2019qrcode

May. 17, 2019

Favorites Print
May. 17, 2019
Isagro sales decreased 8.3% to 38.7 Euro million in the first quarter 2019, and its EBITDA dropped by 6.7% to 4.2 million in this quarter.


On a like-for-like basis, in 2019 Isagro expects a substantial consolidation of 2018 revenues from agropharma, with expectations of a significant growth in the mid-term thanks particularly to the new fungicide Fluindapyr. It is thus confirmed the objective of Isagro to achieve a turnover of 200 Euro million in the mid-term, also catching opportunities of external growth, with a better definition of its asset allocation.

Source: Isagro

Picture 0/1200

More from AgroNews

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.